GlassScriptPhysician profile
Dennis C Matzkin
NPI 1912968371
$3,388.56
in general payments reported to CMS, 2019-2025
19 companies · $300 in 2025
The $300 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $381 · 2020: $389 · 2021: $400 · 2022: $981 · 2023: $499 · 2024: $439 · 2025: $300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,237.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,530.19 | 2019-2025 | Clareon, Clareon Panoptix Pro, Ngenuity |
| Allergan, INC. | $303.96 | 2019-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $257.57 | 2020-2024 | Tecnis Iol |
| Regeneron Healthcare Solutions, INC. | $173.57 | 2023-2025 | Eylea, Eylea Hd |
| Genentech USA, INC. | $165.12 | 2019-2025 | Vabysmo |
| Glaukos Corporation | $149.56 | 2020 | |
| Horizon Therapeutics Plc | $139.09 | 2021-2022 | |
| Mallinckrodt Enterprises LLC | $121.83 | 2019 | |
| Aerie Pharmaceuticals, INC. | $97.41 | 2019 | |
| New World Medical,INC. | $96.81 | 2021 | |
| Biotissue Holdings INC. | $62.13 | 2019-2024 | |
| Ivantis, INC | $59.72 | 2020 | |
| Abbvie INC. | $49.75 | 2022-2025 | |
| Oyster Point Pharma, INC. | $42.15 | 2022-2025 | Tyrvaya |
| Optos, INC. | $33.84 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $30.26 | 2022-2023 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Light Adjustable Lens (Rxlal) |
| Ocular Therapeutix, INC. | $27.69 | 2022-2023 | Dextenza |
| Rayner Intraocular Lenses Limited | $27.16 | 2025 | Rayone Spheric, Rayone Aspheric, Rayner Cataract Set 1 |
| Novartis Pharmaceuticals Corporation | $20.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Matzkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.